Exploring the health and wellness news of Martinique

Provided by AGP

Got News to Share?

Health Monthly Martinique: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Monthly Martinique.

Press releases published on May 5, 2026

Verrica Pharmaceuticals Announces Upcoming Presentation of Phase 2 Data Highlighting the Potential Abscopal Effects of VP-315 in the Treatment of Basal Cell Carcinoma at the 2026 Society for Investigative Dermatology (SID) Annual Meeting 
OnKure Therapeutics Reports First Quarter 2026 Financial Results
Korro to Participate in Upcoming Investor Conferences
Adaptive Biotechnologies Reports First Quarter 2026 Financial Results
Myriad Genetics Reports First Quarter 2026 Financial Results; Reiterates 2026 Financial Guidance Reflecting Ongoing Progress in the Cancer Care Continuum Business
Iridex to Report First Quarter 2026 Financial Results on May 19, 2026
Amwell® Announces Results for First Quarter 2026
Avalo Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Standard BioTools Reports First Quarter 2026 Financial Results
Relay Therapeutics Reports First Quarter 2026 Financial Results and Corporate Updates
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 2026 Financial Results
Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Ligand to Participate in May Investor Conferences
Ultragenyx Reports First Quarter 2026 Financial Results and Corporate Update
HealthEquity Announces First Quarter Earnings Release Date and Investor Conference Schedule
Carlsmed® Reports First Quarter 2026 Financial Results 
Avalyn to Present Patient-Centered Research on AP01 Delivery and Supportive Care Experiences at American Thoracic Society 2026 International Conference
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dentsply Sirona Reports First Quarter 2026 Results
Avalo Therapeutics Achieves Positive Topline Results in Phase 2 LOTUS Trial of Abdakibart (AVTX-009) in Moderate to Severe Hidradenitis Suppurativa

Share us

on your social networks:

Sign up for:

Health Monthly Martinique

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.